Literature DB >> 4185855

Cyclophosphamide treatment of mouse systemic lupus erythematosus.

R E Horowitz, E L Dubois, J Weiner, L Strain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4185855

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  10 in total

1.  Experimental immune complex glomerulopathy: immunomorphological aspects and correlations with human disease.

Authors:  P Rossmann; I Ríha; I Hajdu
Journal:  Int Urol Nephrol       Date:  1975       Impact factor: 2.370

2.  Therapeutic effect of beta-[1-phenyl-5-bis(beta-chloroethyl)-amino-benzimidazolyl-(2)-DL-alanin (ZIMET 3164) on immune complex nephritis of NZB hybrid mice.

Authors:  J Güttner
Journal:  Agents Actions       Date:  1979-12

3.  Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice.

Authors:  E Lemmel; E R Hurd; M Ziff
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

4.  Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZBxNZW) F1 hybrid mice.

Authors:  B M Greenwood; A Voller
Journal:  Clin Exp Immunol       Date:  1970-12       Impact factor: 4.330

5.  The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice.

Authors:  E R Hurd; M Ziff
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

6.  The effect of chronic daily cyclophosphamide administration on established antibody responses.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1981-10       Impact factor: 4.330

7.  Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats.

Authors:  P Y Paterson; D G Drobish
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

8.  Thiamphenicol and lupus nephritis. The effects of long-term therapy on kidney function and pathology: a pilot study.

Authors:  L O Simpson; I Aarons; J B Howie
Journal:  Br J Exp Pathol       Date:  1979-02

9.  Late treatment of murine lupus erythematosus with dactinomycin (actinomycin D). I. Course and longevity.

Authors:  A E Gabrielsen; C T Olsen
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  Reversal of nzb/nzw disease with total lymphoid irradiation.

Authors:  B L Kotzin; S Strober
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.